Mirapex and Meniscus lesion - a phase IV clinical study of FDA data

Summary:

Meniscus lesion is reported as a side effect among people who take Mirapex (pramipexole dihydrochloride), especially for people who are male, 60+ old, also take Neurontin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Meniscus lesion when taking Mirapex. It is created by eHealthMe based on reports of 19,316 people who have side effects when taking Mirapex from the FDA, and is updated regularly.

What is Mirapex?

Mirapex has active ingredients of pramipexole dihydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 20,622 Mirapex users. Check the latest studies of Mirapex.

What is Meniscus lesion?

Meniscus lesion (lesion of a crescent-shaped piece of cartilage between the femur and the tibia) is found to be associated with 462 drugs and 520 conditions by eHealthMe. Check the latest studies of Meniscus lesion.

On Jul, 16, 2026

19,316 people reported to have side effects when taking Mirapex.
Among them, 29 people (0.15%) have Meniscus lesion.

Among these 29 people:

What is the gender of people who have Meniscus lesion when taking Mirapex? *

female: 39.13 %
male: 60.87 %

What is the age of people who have Meniscus lesion when taking Mirapex? *

What are other drugs people take besides Mirapex? *

What are other side effects people have besides Meniscus lesion? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 21 people, 72.41%
Pneumonia: 20 people, 68.97%
Anaemia (lack of blood): 19 people, 65.52%
Pain In Extremity: 17 people, 58.62%
Dyspnea (difficult or laboured breathing): 16 people, 55.17%
Joint Pain: 16 people, 55.17%
Back Pain: 15 people, 51.72%
Stress And Anxiety: 15 people, 51.72%
Muscle Spasms (muscle contraction): 15 people, 51.72%
Urinary Tract Infection: 14 people, 48.28%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 41.38%
Chronic Renal Failure (kidney failure): 7 people, 24.14%
Osteoporosis (bones weak and more likely to break): 5 people, 17.24%
Hepatitis C: 4 people, 13.79%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 10.34%
High Blood Pressure: 3 people, 10.34%
Hypersensitivity: 3 people, 10.34%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.90%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 6.90%
Anaemia (lack of blood): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Mirapex and have Meniscus lesion?

- Check whether Meniscus lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirapex:

Mirapex (20,622 reports)

Meniscus lesion treatments and more:

Meniscus lesion (3,621 reports)

Browse all side effects of Mirapex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meniscus lesion:

Meniscus lesion (462 drugs)

Browse all the conditions that are associated with Meniscus lesion:

Meniscus lesion (520 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pramipexole dihydrochloride (the active ingredients of Mirapex) and Mirapex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.